BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. The Lancet 2020;396:1675-88. [DOI: 10.1016/s0140-6736(20)31548-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 11] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Brierley SM, Grundy L, Castro J, Harrington AM, Hannig G, Camilleri M. Guanylate cyclase-C agonists as peripherally acting treatments of chronic visceral pain. Trends Pharmacol Sci 2021:S0165-6147(21)00217-0. [PMID: 34865885 DOI: 10.1016/j.tips.2021.11.002] [Reference Citation Analysis]
2 Iribarren C, Magnusson MK, Vigsnæs LK, Aziz I, Amundsen ID, Šuligoj T, Juge N, Patel P, Sapnara M, Johnsen L, Sørensen N, Sundin J, Törnblom H, Simrén M, Öhman L. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome. Nutrients 2021;13:3836. [PMID: 34836092 DOI: 10.3390/nu13113836] [Reference Citation Analysis]
3 Zhu LY, Huang BW, Zhang XL, Zhu N. Progress in application of probiotics, prebiotics, and synbiotics in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2022; 30(8): 375-380 [DOI: 10.11569/wcjd.v30.i8.375] [Reference Citation Analysis]
4 Chen GR, Xie XF, Peng C. Treatment of Irritable Bowel Syndrome by Chinese Medicine: A Review. Chin J Integr Med 2021. [PMID: 34546535 DOI: 10.1007/s11655-021-3521-4] [Reference Citation Analysis]
5 Bellini M, Berti G, Bonfrate L, Ciranni F, Di Ciaula A, Di Ruscio M, Dell'Era A, Lambiase C, Noto A, Pancetti A, Portincasa P, Rettura F. Use of GELSECTAN® in Patients with Irritable Bowel Syndrome (IBS): an Italian Experience. Patient Prefer Adherence 2021;15:1763-74. [PMID: 34413634 DOI: 10.2147/PPA.S318859] [Reference Citation Analysis]
6 Coffey JC, Byrnes KG, Walsh DJ, Cunningham RM. Update on the mesentery: structure, function, and role in disease. Lancet Gastroenterol Hepatol 2022;7:96-106. [PMID: 34822760 DOI: 10.1016/S2468-1253(21)00179-5] [Reference Citation Analysis]
7 Loosen SH, Jördens MS, Luedde M, Modest DP, Labuhn S, Luedde T, Kostev K, Roderburg C. Incidence of Cancer in Patients with Irritable Bowl Syndrome. J Clin Med 2021;10:5911. [PMID: 34945206 DOI: 10.3390/jcm10245911] [Reference Citation Analysis]
8 Balmus I, Copolovici D, Copolovici L, Ciobica A, Gorgan DL. Biomolecules from Plant Wastes Potentially Relevant in the Management of Irritable Bowel Syndrome and Co-Occurring Symptomatology. Molecules 2022;27:2403. [DOI: 10.3390/molecules27082403] [Reference Citation Analysis]
9 Rexwinkel R, Vlieger AM, Saps M, Tabbers MM, Benninga MA. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified. Eur J Pediatr 2022. [PMID: 35460383 DOI: 10.1007/s00431-022-04459-y] [Reference Citation Analysis]
10 Wollny T, Daniluk T, Piktel E, Wnorowska U, Bukłaha A, Głuszek K, Durnaś B, Bucki R. Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome. Pathogens 2021;10:1545. [PMID: 34959500 DOI: 10.3390/pathogens10121545] [Reference Citation Analysis]
11 Gros M, Gros B, Mesonero JE, Latorre E. Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management. J Clin Med 2021;10:3429. [PMID: 34362210 DOI: 10.3390/jcm10153429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Barberio B, Savarino EV, Black CJ, Ford AC. Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta-analysis. Neurogastroenterol Motil 2021;:e14279. [PMID: 34672052 DOI: 10.1111/nmo.14279] [Reference Citation Analysis]
13 Weber HC. Editorial: Gastrointestinal regulatory peptides. Curr Opin Endocrinol Diabetes Obes 2021;28:196-7. [PMID: 33428343 DOI: 10.1097/MED.0000000000000613] [Reference Citation Analysis]
14 Lu S, Jiang HY, Shi YD. Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta-analysis. Acta Neurol Scand 2021. [PMID: 34908158 DOI: 10.1111/ane.13570] [Reference Citation Analysis]
15 Yadav YS, Eslick GD, Talley NJ. Review article: irritable bowel syndrome: natural history, bowel habit stability and overlap with other gastrointestinal disorders. Aliment Pharmacol Ther 2021;54 Suppl 1:S24-32. [PMID: 34927758 DOI: 10.1111/apt.16624] [Reference Citation Analysis]
16 Arokiadoss A, Weber HC. Targeted pharmacotherapy of irritable bowel syndrome. Curr Opin Endocrinol Diabetes Obes 2021;28:214-21. [PMID: 33481423 DOI: 10.1097/MED.0000000000000618] [Reference Citation Analysis]
17 Chen J, Barandouzi ZA, Lee J, Xu W, Feng B, Starkweather A, Cong X. Psychosocial and Sensory Factors Contribute to Self-Reported Pain and Quality of Life in Young Adults with Irritable Bowel Syndrome. Pain Management Nursing 2022. [DOI: 10.1016/j.pmn.2021.12.004] [Reference Citation Analysis]
18 Hillestad EMR, van der Meeren A, Nagaraja BH, Bjørsvik BR, Haleem N, Benitez-Paez A, Sanz Y, Hausken T, Lied GA, Lundervold A, Berentsen B. Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome. World J Gastroenterol 2022; 28(4): 412-431 [DOI: 10.3748/wjg.v28.i4.412] [Reference Citation Analysis]
19 Tseng PH, Chiu HM, Tu CH, Wu MS, Ho HN, Chen MJ. Obesity Exacerbates Irritable Bowel Syndrome-Related Sleep and Psychiatric Disorders in Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne) 2021;12:779456. [PMID: 34867827 DOI: 10.3389/fendo.2021.779456] [Reference Citation Analysis]
20 Sun Y, Chen X, Wang S, Deng M, Xie Y, Wang X, Chen J, Hesketh T. Gluten-free Diet Reduces the Risk of Irritable Bowel Syndrome: A Mendelian Randomization Analysis. Front Genet 2021;12:684535. [PMID: 34899821 DOI: 10.3389/fgene.2021.684535] [Reference Citation Analysis]
21 Zheng Y, Ching J, Cheng CW, Lam WC, Chan KL, Zhang X, Lam PY, Wu XY, Zhong LLD, Cao PH, Lo CW, Cheong PK, Lin Z, Koh M, Wu J, Bian ZX. Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial. Chin Med 2021;16:117. [PMID: 34774080 DOI: 10.1186/s13020-021-00530-2] [Reference Citation Analysis]
22 Brenner DM, Lacy BE. Antispasmodics for Chronic Abdominal Pain: Analysis of North American Treatment Options. Am J Gastroenterol 2021;116:1587-600. [PMID: 33993133 DOI: 10.14309/ajg.0000000000001266] [Reference Citation Analysis]
23 Yan D, Ra OH, Yan B. The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance. Anim Dis 2021;1:15. [PMID: 34778881 DOI: 10.1186/s44149-021-00017-5] [Reference Citation Analysis]
24 Maslennikov R, Poluektova E, Ivashkin V, Svistunov A. Diarrhoea in adults with coronavirus disease-beyond incidence and mortality: a systematic review and meta-analysis. Infect Dis (Lond) 2021;53:348-60. [PMID: 33583306 DOI: 10.1080/23744235.2021.1885733] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
25 Chen J, Zhang Y, Barandouzi ZA, Lee J, Zhao T, Xu W, Chen M, Feng B, Starkweather A, Cong X. The effect of self-management online modules plus nurse-led support on pain and quality of life among young adults with irritable bowel syndrome: a randomized controlled trial. International Journal of Nursing Studies 2022. [DOI: 10.1016/j.ijnurstu.2022.104278] [Reference Citation Analysis]
26 Pradeep S, Mehanna R. Gastrointestinal disorders in hyperkinetic movement disorders and ataxia. Parkinsonism Relat Disord 2021;90:125-33. [PMID: 34544654 DOI: 10.1016/j.parkreldis.2021.09.005] [Reference Citation Analysis]
27 Camilleri M, Magnus Y, Carlson P, Wang XJ, Chedid V, Maselli D, Taylor A, McKinzie S, Kengunte Nagaraj N, Busciglio IA, Nair AA. Differential mRNA Expression in Ileal and Colonic Biopsies in Irritable Bowel Syndrome with Diarrhea or Constipation. Am J Physiol Gastrointest Liver Physiol 2022. [PMID: 35502856 DOI: 10.1152/ajpgi.00063.2022] [Reference Citation Analysis]
28 Xu X, Dong Q, Zhong Q, Xiu W, Chen Q, Wang J, Zhou Z. The Flavonoid Kurarinone Regulates Macrophage Functions via Aryl Hydrocarbon Receptor and Alleviates Intestinal Inflammation in Irritable Bowel Syndrome. J Inflamm Res 2021;14:4347-59. [PMID: 34539182 DOI: 10.2147/JIR.S329091] [Reference Citation Analysis]
29 Tan X, Pei W, Xie C, Wang Z, Liu J, Cheng Y, Mao T, Shi L, Zhao X, Lu Q, Sun Z, Kou F, Jiang H, Li J. Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway. Evid Based Complement Alternat Med 2021;2021:6679348. [PMID: 34239591 DOI: 10.1155/2021/6679348] [Reference Citation Analysis]
30 Singh R, Wei L, Ghoshal UC. Micro-organic basis of functional gastrointestinal (GI) disorders: Role of microRNAs in GI pacemaking cells. Indian J Gastroenterol 2021;40:102-10. [PMID: 33738768 DOI: 10.1007/s12664-021-01159-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Samasca G, Lerner A. Celiac disease in the COVID-19 pandemic. J Transl Autoimmun 2021;4:100120. [PMID: 34485888 DOI: 10.1016/j.jtauto.2021.100120] [Reference Citation Analysis]
32 Tang M, Shen X, Chai J, Cheng J, Wang D. Dose-Effect Relationship Between Gastric Cancer and Common Digestive Tract Symptoms and Diagnoses in Anhui, China. Cancer Manag Res 2021;13:4955-66. [PMID: 34188548 DOI: 10.2147/CMAR.S313771] [Reference Citation Analysis]
33 Singh R, Zogg H, Ro S. Role of microRNAs in Disorders of Gut-Brain Interactions: Clinical Insights and Therapeutic Alternatives. J Pers Med 2021;11:1021. [PMID: 34683162 DOI: 10.3390/jpm11101021] [Reference Citation Analysis]
34 Huang H, Lu L, Chen Y, Zeng Y, Xu C. The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis. Nutr J 2022;21:24. [PMID: 35509010 DOI: 10.1186/s12937-022-00777-x] [Reference Citation Analysis]
35 Yu Z, Liu L, Lai Y, Tian Z, Yang L, Zhang Q, Liang F, Yu S, Zheng Q. Altered Resting Brain Functions in Patients With Irritable Bowel Syndrome: A Systematic Review. Front Hum Neurosci 2022;16:851586. [DOI: 10.3389/fnhum.2022.851586] [Reference Citation Analysis]
36 Hahn J, Choi J, Chang MJ. Effect of Low FODMAPs Diet on Irritable Bowel Syndromes: A Systematic Review and Meta-Analysis of Clinical Trials. Nutrients 2021;13:2460. [PMID: 34371973 DOI: 10.3390/nu13072460] [Reference Citation Analysis]
37 Loosen SH, Kostev K, Jördens MS, Luedde T, Roderburg C. Overlap between irritable bowel syndrome and common gastrointestinal diagnoses: a retrospective cohort study of 29,553 outpatients in Germany. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02118-y] [Reference Citation Analysis]
38 Wu J, Masuy I, Biesiekierski JR, Fitzke HE, Parikh C, Schofield L, Shaikh H, Bhagwanani A, Aziz Q, Taylor SA, Tack J, Van Oudenhove L. Gut-brain axis dysfunction underlies FODMAP-induced symptom generation in irritable bowel syndrome. Aliment Pharmacol Ther 2022. [PMID: 35166384 DOI: 10.1111/apt.16812] [Reference Citation Analysis]
39 Nakov R, Dimitrova-Yurukova D, Snegarova V, Nakov V, Fox M, Heinrich H. Increased prevalence of gastrointestinal symptoms and disorders of gut-brain interaction during the COVID-19 pandemic: An internet-based survey. Neurogastroenterol Motil 2021;:e14197. [PMID: 34145679 DOI: 10.1111/nmo.14197] [Reference Citation Analysis]
40 Chen YM, Li Y, Wang X, Wang ZL, Hou JJ, Su S, Zhong WL, Xu X, Zhang J, Wang BM, Wang YM. Effect of Bacillus subtilis, Enterococcus faecium, and Enterococcus faecalis supernatants on serotonin transporter expression in cells and tissues. World J Gastroenterol 2022; 28(5): 532-546 [DOI: 10.3748/wjg.v28.i5.532] [Reference Citation Analysis]
41 Lackner JM, Gudleski GD, Radziwon CD, Krasner SS, Naliboff BD, Vargovich AM, Borden AB, Mayer EA. Cognitive flexibility improves in cognitive behavior therapy for irritable bowel syndrome but not nonspecific education/support. Behaviour Research and Therapy 2022. [DOI: 10.1016/j.brat.2022.104033] [Reference Citation Analysis]
42 Capozza M, Laforgia N, Rizzo V, Salvatore S, Guandalini S, Baldassarre M. Probiotics and Functional Gastrointestinal Disorders in Pediatric Age: A Narrative Review. Front Pediatr 2022;10:805466. [DOI: 10.3389/fped.2022.805466] [Reference Citation Analysis]
43 Wei L, Singh R, Ro S, Ghoshal UC. Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology. JGH Open 2021;5:976-87. [PMID: 34584964 DOI: 10.1002/jgh3.12528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Biruete A, Shin A, Kistler BM, Moe SM. Feeling gutted in chronic kidney disease (CKD): Gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis. Semin Dial 2021. [PMID: 34708456 DOI: 10.1111/sdi.13030] [Reference Citation Analysis]
45 Häuser W, Andresen V. [Functional gastrointestinal disorders]. Dtsch Med Wochenschr 2022;147:595-604. [PMID: 35545068 DOI: 10.1055/a-1554-1739] [Reference Citation Analysis]
46 Hou JJ, Wang X, Wang YM, Wang BM. Interplay between gut microbiota and bile acids in diarrhoea-predominant irritable bowel syndrome: a review. Crit Rev Microbiol 2021;:1-18. [PMID: 34936854 DOI: 10.1080/1040841X.2021.2018401] [Reference Citation Analysis]
47 Mishima Y, Ishihara S. Enteric Microbiota-Mediated Serotonergic Signaling in Pathogenesis of Irritable Bowel Syndrome. Int J Mol Sci 2021;22:10235. [PMID: 34638577 DOI: 10.3390/ijms221910235] [Reference Citation Analysis]
48 BouSaba J, Sannaa W, McKinzie S, Vijayvargiya P, Chedid V, Wang XJ, Atieh J, Zheng T, Brandler J, Taylor AL, Busciglio I, Harmsen WS, Camilleri M. Impact of Bile Acid Diarrhea in Patients With Diarrhea-Predominant Irritable Bowel Syndrome on Symptoms and Quality of Life. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01273-8. [PMID: 34871814 DOI: 10.1016/j.cgh.2021.11.035] [Reference Citation Analysis]
49 Rangan V, Singh P, Ballou S, Hassan R, Yu V, Katon J, Nee J, Iturrino J, Lembo A. Improvement in constipation and diarrhea is associated with improved abdominal pain in patients with functional bowel disorders. Neurogastroenterol Motil 2021;:e14253. [PMID: 34520617 DOI: 10.1111/nmo.14253] [Reference Citation Analysis]
50 Chen XF, Guo Y, Lu XQ, Qi L, Xu KH, Chen Y, Li GX, Ding JP, Li J. Aberrant Intraregional Brain Activity and Functional Connectivity in Patients With Diarrhea-Predominant Irritable Bowel Syndrome. Front Neurosci 2021;15:721822. [PMID: 34539337 DOI: 10.3389/fnins.2021.721822] [Reference Citation Analysis]
51 Zhu X, Hong G, Li Y, Yang P, Cheng M, Zhang L, Li Y, Ji L, Li G, Chen C, Zhong C, Jin Y, Yang M, Xiong H, Qian W, Ding Z, Ning K, Hou X. Understanding of the Site-Specific Microbial Patterns towards Accurate Identification for Patients with Diarrhea-Predominant Irritable Bowel Syndrome. Microbiol Spectr 2021;9:e0125521. [PMID: 34937163 DOI: 10.1128/Spectrum.01255-21] [Reference Citation Analysis]
52 Chlebicz-Wójcik A, Śliżewska K. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review. Biomolecules 2021;11:1154. [PMID: 34439821 DOI: 10.3390/biom11081154] [Reference Citation Analysis]
53 Bravo-Vázquez LA, Medina-Ríos I, Márquez-Gallardo LD, Reyes-Muñoz J, Serrano-Cano FI, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. Functional Implications and Clinical Potential of MicroRNAs in Irritable Bowel Syndrome: A Concise Review. Dig Dis Sci 2022. [PMID: 35507132 DOI: 10.1007/s10620-022-07516-6] [Reference Citation Analysis]
54 BouSaba J, Sannaa W, Camilleri M. Pain in irritable bowel syndrome: Does anything really help? Neurogastroenterol Motil 2022;34:e14305. [PMID: 34859929 DOI: 10.1111/nmo.14305] [Reference Citation Analysis]
55 Ma J, Wang FY, Xu L, Wang YF, Tang XD. Mechanism of mast cell-mediated COX2-PGE2-Eps signaling pathway in visceral hypersensitivity in irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2021; 29(6): 306-311 [DOI: 10.11569/wcjd.v29.i6.306] [Reference Citation Analysis]
56 Wu J, Lv L, Wang C. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials. Front Cell Infect Microbiol 2022;12:827395. [DOI: 10.3389/fcimb.2022.827395] [Reference Citation Analysis]
57 Jeong B, Sung TS, Jeon D, Park KJ, Jun JY, So I, Hong C. Inhibition of TRPC4 channel activity in colonic myocytes by tricyclic antidepressants disrupts colonic motility causing constipation. J Cell Mol Med 2022. [PMID: 35560982 DOI: 10.1111/jcmm.17348] [Reference Citation Analysis]
58 Zhao T, Pei L, Ning H, Guo J, Song Y, Zhou J, Chen L, Sun J, Mi Z. Networks Are Associated With Acupuncture Treatment in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: A Resting-State Imaging Study. Front Hum Neurosci 2021;15:736512. [PMID: 34720908 DOI: 10.3389/fnhum.2021.736512] [Reference Citation Analysis]
59 de Souza SS, Pierezan MD, de Souza Hassemer G, Lima CMG, De Dea Lindner J, Miotto M, Verruck S. Effect of Prebiotics and Synbiotics Carried by Food over Irritable Bowel Syndrome Symptoms: A Systematic Review. Dairy 2022;3:148-62. [DOI: 10.3390/dairy3010012] [Reference Citation Analysis]
60 Donnet A, Hasan SS, Whorwell PJ. Hypnotherapy for irritable bowel syndrome: patient expectations and perceptions. Therap Adv Gastroenterol 2022;15:175628482210742. [DOI: 10.1177/17562848221074208] [Reference Citation Analysis]
61 Geroin C, Stone J, Camozzi S, Demartini B, Gandolfi M, Tinazzi M. Triggers in functional motor disorder: a clinical feature distinct from precipitating factors. J Neurol 2022. [PMID: 35441888 DOI: 10.1007/s00415-022-11102-1] [Reference Citation Analysis]
62 Holland AM, Bon-Frauches AC, Keszthelyi D, Melotte V, Boesmans W. The enteric nervous system in gastrointestinal disease etiology. Cell Mol Life Sci 2021;78:4713-33. [PMID: 33770200 DOI: 10.1007/s00018-021-03812-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]